Kitang, James .
HRN: 11-71-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/08/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/08/2024
07/15/2024
IV
2.25g
Q8h
DM Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes